ULTIMOVACS AS DK1 Aktie - Unternehmensdaten & Kurse - NO0010851603 | MoneyPeak

ULTIMOVACS AS DK1

Share · NO0010851603 · A2PKSD (XOSL)

No Price

n/a

Share Float & Liquidity

Free Float 68,60 %

Shares Float 23,6 M

Shares Outstanding 34,41 M

Company Profile for ULTIMOVACS AS DK1 Share

Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

AI Analysis of ULTIMOVACS AS DK1

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of ULTIMOVACS AS DK1

No AI threads available for this company yet.

Company Data

Name ULTIMOVACS AS DK1

Company Ultimovacs ASA

Website https://ultimovacs.com

Primary Exchange

OSLO BORS

WKN A2PKSD

ISIN NO0010851603

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Hans Vassgard Eid

Market Capitalization 71 Mio

Country Norway

Currency EUR

Employees 0,0 T

Address Ullernchausséen 64, 0379 Oslo

IPO Date 2019-06-03

Ticker Symbols

Name	Symbol
OSLO BORS	ULTI.OL
Frankfurt	7UM.F

More Shares

Investors who hold ULTIMOVACS AS DK1 also have the following shares in their portfolio:

BCA CARIGE S.P.A Share

NORDLB IS. 13/23 VAR Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2026